This implies a common tumor progenitor cell population carrying the IDH1- mutation which later is separated by the occurrence of a TP53- mutation for the astrocytic and a combined LOH1p/19q for the oligodendroglial tumor component, similar to the model for tumor development in astrocytomas and oligodendrogliomas. The gene discussed is TP53; the disease is oligodendroglioma.